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ABSTRACT
ObjectiveTocomparetheeffectsofdifferenttypesoflocal
anaesthetic for pain control during outpatient
hysteroscopy.
Design Systematic review and meta-analysis of
randomised controlled trials.
Setting Outpatient hysteroscopy clinics.
Participants Women undergoing diagnostic or operative
hysteroscopy as outpatients—that is, without general
anaesthesia.
Study selection criteria Medline, Embase, CINAHL, the
Cochrane library, and reference lists of relevant studies.
Two reviewers independently selected trials. Data were
abstracted on quality, characteristics, and results.
ResultsTherewere20trials(2851participants).Datafrom
15 of these were meta-analysed in subgroups defined by
type of intervention and study quality. Intracervical
(standardised mean difference −0.36, 95% confidence
interval −0.61 to −0.10, I
2=0%) and paracervical (−1.28,
−2.22 to −0.35, I
2=97%) injections of local anaesthetic
significantly reduced the pain in women undergoing
hysteroscopy as outpatients, whereas transcervical
(−0.11, −0.31 to 0.10, I
2=27%) and topical application
(−0.32, −0.97 to 0.33, I
2= 90%) did not. Meta-regression
showed that paracervical injection was superior to the
other anaesthetic methods (P=0.04), a finding that was
supported by the high quality subgroup of studies. Use of
local anaesthetic did not have a significant effect on the
incidence of vasovagal episodes (P=0.09).
Conclusions Paracervical local anaesthetic injection is
the best method of pain control for women undergoing
hysteroscopy as outpatients.
INTRODUCTION
Ambulatory hysteroscopy is a safe, feasible, and accu-
rate procedure for diagnosing intrauterine pathology.
1
Provision of outpatient based diagnostic and operative
services is gaining prominence as a standard of care,
2
but the experience of pain can be a deterrent for
patients offered outpatient diagnostic hysteroscopy.
Individual studies examining the effect of local anaes-
thetics are often imprecise and provide conflicting
results.
3 Though a recent review examined the use of
paracervicalinjectionforcervicaldilatationanduterine
interventions in various obstetric and gynaecological
procedures,
4 there is no comprehensive review evalu-
ating comparative effectiveness of the whole range of
local anaesthetic methods for specific procedures.
We conducted a systematic review to determine the
effects of various local anaesthetic techniques used for
pain control during outpatient hysteroscopy.
METHODS
We conducted the review prospectively, devising a
protocol based on widely documented methods.
56
Data sources and searches
We conducted a comprehensive literature search to
identify studies that evaluated the use of local anaes-
thetic to reduce pain during outpatient hysteroscopy.
The databases searched included Medline (from 1950
toSeptember2008),Embase(from1980toSeptember
2008), CINAHL (from 1981 to September 2008), and
the Cochrane library. We used a combination of the
keywords “hysteroscopy,”“ vaginoscopy,”“ local
anaesthetic,” and their associated medical subject
headings (MeSH) to search Medline, Embase, and
CINAHL. The Cochrane library was searched with
the keywords “hysteroscopy and “anaesthetic.” To
ensure maximum sensitivity we placed no limits or fil-
ters on the searches. We also checked the reference
sectionsofselectedoriginalarticlesforrelevantpapers
and retrieved any that we thought were relevant but
had not been retrieved by the database searches.
Study selection
Population—Included women were undergoing diag-
nostic or operative hysteroscopy as outpatients—that
is, without general anaesthesia.
Intervention—Use of local anaesthetic for pain relief
duringtheprocedure(forexample,intracervicalblock,
paracervical block, local anaesthetic instilled into the
cavityorappliedtotheectocervix,fig1)wascompared
with no intervention, placebo, oral analgesics, or con-
scious sedation.
Outcome—Our outcomes were assessment of pain
(primaryoutcome)andvasovagalepisodes(secondary
outcome) associated with the procedure.
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Inclusion process—Two authors (NAMC and TJC)
independently reviewed the titles and abstracts from
the electronic literature searches and selected citations
if they seemed to fulfil the selection criteria. The com-
plete manuscripts of selected citations were then
reviewed in full to determine inclusion or exclusion.
Studies were excluded if numerical data assessing
pain were not presented explicitly (for example, some
papersdisplayedresultsgraphicallysuchthatthemean
painscorescouldonlybeestimatedfromthegraphand
given this ambiguity were excluded from further ana-
lysis). We aimed to contact authors but were unable to
dosoinsomeinstances
7orreceivednoreplyinothers.
8
Whenduplicatedatawerepublished,weincludedonly
the most up to date, larger series. Any disagreements
aboutstudyeligibilitywereresolvedbyconsensus.We
assessed agreementbetween raters with the κ statistic.
9
Data extraction
One of the authors (NAMC) used a piloted extraction
form to record data from the selected studies. Data
were collected to determine study quality (the confi-
dence that the trial design, conduct, and analysis has
minimised or avoided biases in its treatment
comparisons)
10 according to Jadad’s scoring method,
which allowed us to calculate a quality score on a 5
point scale
1112 (table 1). Papers that scored >3 points
were considered to be of high quality. We also col-
lected data regarding the intervention, technical
aspects of the hysteroscopy, assessment of pain, and
vasovagal attacks.
Studies varied in how they assessed pain. Some stu-
dies gave an overall pain score for the procedure.
Othersscoredeachofthestepsseparately(forinstance,
tenaculum application, administration of anaesthetic
orplacebo,insertionofthescope,inspectionofuterine
cavity, during the biopsy, and at intervals after the end
of the procedure). When available we used the overall
pain score for the meta-analysis, but when the indivi-
dualstepswerescored,andnooverallscorewasgiven,
we used the score relating to inspection of the uterine
cavity. When scores were given only after the proce-
dure,weusedthemostimmediatescore.About20%of
women experience vasovagal reactions during outpa-
tient hysteroscopy,
13 possibly caused by para-
sympathetic nerve stimulation during passage of
instruments through the cervical canal. Blocking the
nerves with local anaesthetic might reduce the inci-
denceofattacks,
71415butonestudyhasshownconflict-
ing results.
16
To examine the incidence of vasovagal episodes in
relation to use of local anaesthetics, we extracted data as
2×2 contingency tables (occurrence v non-occurrence).
Data synthesis
We evaluated the effect of local anaesthetic on pain
relief in outpatient hysteroscopy using standardised
mean differences (SMD). This measure was chosen as
it allowed comparison of outcome data from studies
that used different scales to quantify pain.
6
Heterogeneity was assessed by examining forest
plots and the I
2 statistic, which if greater than 75% sug-
gests considerable heterogeneity.
6 Meta-analysis was
performed for data overall and by subgroups defined
bytypeofinterventionandstudyquality.Weweighted
studiesbytheinverseofthevarianceandusedrandom
effects models as standard as they give conservative
estimates of effect.
6 We used meta-regression analysis
to determine whether any of the four types of local
Paracervical injection
Topical surface application
Transcervical/intrauterine
instillation
Intracervical injection
Uterus
Vagina
Cervix
Fig 1 | Different methods of administration of local anaesthetic
for outpatient hysteroscopy
Table 1 |Methodological quality assessment (Jadad scoring system
11) of studies included in
systematic review of use of local anaesthetic during outpatient hysteroscopy
Study Randomised ±1* Double blind ±1*
Withdrawals
and dropouts Total
Quality
(>3=high)
Al-Sunaidi
36 1 1 0 0 1 3 Low
Bellati21 1 0 0 0 1 2 Low
Broadbent
27 1 1 1 1 1 5 High
Cicinelli
1997
14
1 1 1 1 1 5 High
Cicinelli
1998
15
1 1 1 1 1 5 High
Costello
38 1 1 1 1 1 5 High
Davies
24 1 1 1 1 1 5 High
Esteve
35 1 0 1 1 1 4 High
Finikiotis
13 1 −10 0 1 1 L o w
Giorda
30 1 1 0 0 1 3 Low
Guida
22 1 1 0 0 1 3 Low
Kabli
39 1 1 0 0 1 3 Low
Lau 1999
16 1 1 1 1 1 5 High
Lau 2000
32 1 1 1 1 1 5 High
Makris
25 1 0 0 0 1 2 Low
Sagiv
26 1 1 0 0 1 3 Low
Shankar
33 1 1 0 0 1 3 Low
Soriano
34 1 1 1 1 1 5 High
Vercellini
37 1 1 0 0 1 3 Low
Wong
40 1 1 1 1 1 5 High
*Refers to description of randomisation and blinding. If methods are described and are adequate study receives
an extra quality point, if they are inadequate then quality point is deducted.
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17 For the dichoto-
mous outcome of vasovagal attacks we used the Peto
method because of the low incidence of events in the
studies.
18 Analyses were performed with RevMan
software
19 and Stata.
20
RESULTS
Study selection, details, and quality
The literature search yielded 245 citations. Reviewing
the reference lists yielded two further citations. Of
these, 20 studies were considered eligible for inclusion
in the review (fig 2). The inter-rater reliability for the
study selection was good (κ=0.9).
Tables 2, 3, and 4 show details of the study popula-
tions, intervention, outcome assessment, and data
reporting. The quality of the studies varied with defi-
ciencies in randomisation and blinding (fig 3).
Of the 20 selected studies, 18 reported data on local
anaestheticcomparedwithplaceboornothing.Oneof
these studies also reported data for a third randomised
group of patients who received opiate analgesia
(tramadol).
21 Of the two remaining studies, one com-
pared use of local anaesthetic with conscious sedation
(midazolam)
22 and the other compared different local
anaesthetic regimens (paracervical injection v uterosa-
cral ligament injection).
23 Of the 18 papers reporting
data for pain relief, we excluded three from meta-ana-
lysis; two because data were reported as the median
value
24 or the mean but without standard deviation or
standard error,
25 precludingcalculationof the standar-
dised mean difference, and another because of differ-
encesininterventionbetweenthegroupsinadditionto
the use of local anaesthetic.
26 Most of the papers used
continuousvisualanaloguescales(VAS)toassesspain;
other studies used ordinal numerical or descriptive
scales. Most results were reported as mean or median
pain scores. One study used a descriptive scale,
27 and
weappliednumericalvaluestoeachcategory(none=1,
mild=2, moderate=3, and severe=4) and used this to
calculate the mean scores and standard deviations.
28
One study reported raw data,
21 from which we calcu-
lated the mean and standard deviation.
28 The popula-
tions in the two studies
2127 for which we calculated the
meanandstandarddeviationweresufficientlylargefor
us to approximate them to a normal distribution
according to central limit theory.
29 Another study
reported the standard error,
30 which we converted
into the standard deviation.
31
Nine of the selected studies provided data on vaso-
vagal episodes. Four of the studies reported vasovagal
attacks according to a strict definition based on heart
rate, blood pressure, and symptoms
14-1632; four
reported vasovagal symptoms (such as faintness, nau-
sea,pallor)
22253033;andonereportedavasovagalattack
in the complications but did not give any a priori defi-
nition of symptoms or signs.
34
Effect of local anaesthetic
Meta-analysisof15studiesshowedthattheuseoflocal
anaesthetic reduced the amount of pain experienced
during outpatient hysteroscopy (standardised mean
difference −0.54, 95% confidence interval −0.86 to
−0.23,I
2=91%)(fig4).Meta-analysisofthestudiessub-
groupedaccordingtoqualityfoundthatbothpoorand
high quality studies showed a significant benefit with
useoflocalanaesthetic(−0.77,−1.45to−0.08,I
2=95%,
and−0.43,−0.73to−0.12,I
2=83%,respectively)(fig4).
When we grouped the studies into subgroups, three
studies examined intracervical injection,
212735 five
used paracervical injection,
1516303637 five used trans-
cervical application (topical into the uterine
cavity),
1432333839 and two applied the anaesthetic topi-
cally(topicaltothecervixonly).
3440Theuseofanintra-
cervical injection of local anaesthetic significantly
reduced pain (−0.36, −0.61 to −0.10, I
2 =0%) (fig 4).
This finding, however, contrasted with one study
included in the review but included not in the meta-
analysis because of insufficient data, which found no
significant effect of intracervical local anaesthetic on
pain.
25 To examine this conflicting result, we
Potentially relevant citations identified and screened for
  retrieval (n=245):
    Medline, Embase, and CINAHL (n=238)
    Cochrane Library (n=7)  
Citations retrieved for more detailed evaluation (n=37):
  From electronic searches (n=35)
  From references of retrieved papers (n=2)  
Publications selected for appraisal (n=20)  
Citations excluded (n=210):
  Inappropriate population, intervention, or outcome
    measure (n=151)
  Duplicates (n=59)
Subgroups
Intracervical
  v normal saline
  v nil
  v normal saline
    and v im tramadol
Paracervical
  v normal saline
  v nil
  v uterosacral
  v conscious sedation
Transcervical
  v normal saline
  v normal saline
    containing
    anaesthesia
Topical
  v placebo
Total
Included in
systematic
review
1
3
1
2
3
1
1
3
2
3
20
Included in
meta-analysis
of pain
0
2
1
2
3
0
0
3
2
2
15
Included in
meta-analysis
of vasovagal
episodes
1
0
0
2
1
0
1
2
1
1
9
Publications excluded (n=17):
  Not randomised controlled trial (n=11)
  Data not explicitly reported (n=3)
  Data reported in later, larger trials (n=3)
Fig 2 | Study selection process for systematic review of local
anaesthetic for pain relief during outpatient hysteroscopy
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meta-analysis the study in which categorical data had
beentransformed.
27Wefoundnosignificantreduction
in pain with intracervical injection (−0.35, −0.82 to
0.12, I
2 =48%).
Theuseofparacervicalinjectionwasassociatedwith
a significant reduction of pain (−1.28, −2.22 to −0.38,
I
2=97%)(fig4).Theuseoftopicallyadministeredlocal
anaestheticdidnotamelioratepain.Specifically,trans-
cervical local anaesthetic did not significantly reduce
Table 2 |Characteristics of studies that used carbon dioxide as distension medium included in systematic review of use of local anaesthetic during
outpatient hysteroscopy
Study Participants Intervention Comparison Outcome measure Data reported
Bellati
21 (in
Italian, abstract
in English)
Women undergoing diagnostic
outpatient hysteroscopy and
endometrial biopsy
Intracervical injection of 4 ml 2%
mepivicaine, 5 minutes before
procedure, n=40
Group 1: tramadol 100 mg im
50 minutes before procedure, n=40;
group 2: nil, n=40
Ordinal score 0-20 during
hysteroscopy
Mean (SD)
calculated from
raw data
Broadbent
27 Women undergoing diagnostic
outpatient hysteroscopy for
abnormal uterine bleeding. Patients
unable to tolerate procedure were
excluded
Intracervical injection of 10ml 1%
lidocainewith1:200000adrenaline,
at least 5 minutes before procedure,
n=49
Sameprocedurebutwith10ml0.9%
saline, n=48
Pain defined by selecting a category
from none, mild, moderate, and
severe. Graded before, during,
immediately, and 30 minutes after
Mean (SD)
calculated by
assigning
numericalvalue
to groups
Cicinelli 1997
14 Postmenopausalwomenundergoing
diagnostic hysteroscopy and
endometrial biopsy because of
endometrial bleeding
2 ml 2% mepivacaine injected
transcervically through os into
uterine cavity 5 minutes before
procedure, n=40
Same procedure but with 2 ml 0.9%
saline, n=40
VAS 0-20 completed before, during
and 15 minutes after procedure and
during endometrial biopsy
Mean (SD)
Cicinelli 1998
15 Postmenopausalwomenundergoing
diagnostic hysteroscopy and
endometrial biopsy because of
endometrial bleeding
Paracervical block of 10 ml 1.5%
mepivacaine 10minutes before
procedure, n=36
Sameprocedurebutwith10ml0.9%
saline, n=36
VAS 0-20 completed before, during
and 15 minutes after procedure and
during endometrial biopsy
Mean (SD)
Costello
38 Women referred for outpatient
hysteroscopy
Scope passed into cervical os until
“snug.” 5 ml 2% lidocaine injected
through operating channel of scope.
Waited 2 minutes before procedure
continued, n=49
Sameprocedure but with. 5 ml0.9%
saline, n=50
VAS 0-10 cm to score pain during
procedure
Mean (SD)
Davies
24 Women requiring outpatient
hysteroscopy. Exclusions: known
sensitivity to lidocaine, epilepsy,
impaired respiratory or cardiac
function, liver disease, treatment
with tricyclic antidepressants or
monoamine oxidase inhibitors
10% lidocaine sprayed on to
endocervix and through cervical os
intouterinecavity,10spraysintotal,
n=60
Same procedure but with placebo
spray, n=60
VAS 10 cm to score pain as
tenaculum was applied, nozzle of
sprayinsertedintocanal,insertionof
scope, during procedure, during
biopsy, and 5 minutes after
Median VAS
and
interquartile
ranges
Esteve
35 Women attending for outpatient
hysteroscopy
Intracervical injection of 8 ml 2%
lidocaine, n=34
Same procedure but with 8 ml 0.9%
saline, n=28
VAS 0-10 cm to score pain during
hysteroscopy, during biopsy, at end
of procedure, and 30 minutes after
Mean (SD)
Giorda
30 All postmenopausal women referred
for diagnostic outpatient
hysteroscopy. Women who refused
to participate or had allergy to
anaesthesia,previoushysteroscopy,
andpreviousseverevagalreactionto
blind endometrial biopsy excluded
Paracervical injection of 20 ml 1%
mepivacaine at least 5 minutes
before procedure. Hysteroscopy
performed with 5 mm diameter
scope, n=121
Group 1: no paracervical injection,
hysteroscopy performed with 5 mm
scope; group 2: no paracervical
injection. hysteroscopy performed
with 3.5 mm scope, n=119
Visual numerical rating scale, range
0-10, toscorepainduringprocedure
only (patients who received
paracervicalblockaskedtodiscount
the pain from injection)
Mean. SD
calculated from
standard error
Lau 1999
16 Women undergoing diagnostic
outpatient hysteroscopy for
abnormal uterine bleeding
Paracervical injection of 10 ml 2%
lidocaine 5 minutes before
procedure, n=49
Sameprocedurebutwith10ml0.9%
saline, n=50
VAS 10 cm used to score pain when
tenaculum applied, after
paracervical injection, at
hysteroscopy insertion, during
hysteroscopy, after endometrial
biopsy, and 30 minutes after
Mean (SD)
Lau 2000
32 Women scheduled for diagnostic
outpatient hysteroscopy
5 ml 2% lidocaine instilled
transcervically into uterine cavity,
n=45
Same procedure but with 5 ml 0.9%
saline, n=44
VAS 10 cm used to score pain when
tenaculum applied, after the
paracervical injection, at
hysteroscopy insertion, during
hysteroscopy, after endometrial
biopsy, and 30 minutes after
Mean (SD)
Makris
25 Women undergoing diagnostic
outpatient hysteroscopy, with or
without endometrial biopsy
Intracervical injection of 1-3 ml 3%
mepivacaine, 3 minutes before
procedure, n=100
Same procedure but with 1-3 ml
0.9% saline, n=100
Ordinalscale0-10.Patientsaskedto
rate pain experienced during
hysteroscopy and at 30 and
60 minutes after procedure by
circling one number
Mean reported.
Unable to
calculate SD
Wong
40 Women referred for investigation of
abnormal uterine bleeding or
suspected endometrial pathology.
Women who spoke dialect (study
carried out in China) or had other
communication problems were
excluded
4 ml of 2% lidocaine rubbed over
cervix for 20 seconds immediately
before hysteroscopy, n=250
Sameprocedurebutwith4mlofinert
lubricant, n=250
Patients graded severity of pain at
1 minute intervals with PPI scale.
Mean pain score, peak pain score,
andoverallpainscore,calculatedas
were mean pain scores for each of
individual step of procedure
Mean (SD)
VAS= visual analogue scale, im=intramuscular, PPI=present pain intensity scale (verbal descriptors of pain ranked from 0-5 on numerical scale).
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I
2=27%)(fig4).Similarly,therewasnosignificantalle-
viationofpainwhenlocalanaestheticwasappliedtopi-
callytothecervix(−0.32,−0.97to0.33,I
2=90%)(fig4),
though meta-analysis showed substantial heterogene-
ity.Afurtherstudyincludedinthereview,whichcould
not be used for the meta-analysis because it reported
medianvisualanaloguescale scores,showednosignif-
icant difference between topical cervical local anaes-
thetic and placebo for the hysteroscopy but did show
a significant reduction in pain in the local anaesthetic
group during application of a cervical tenaculum
(P=0.005).
24
We performed a further meta-analysis of injectable
local anaesthetic (intracervical and paracervical) com-
pared with topical application (transcervical to uterine
cavity and topical tothe cervix).This showed a benefit
with injectable local anaesthetics (−0.92, −1.51 to
−0.33, I
2 =94%) but not topical ones (−0.17, −0.38 to
0.03, I
2 =62%). Meta-regression analysis showed that
paracervical injection was significantly more effective
than the other methods of anaesthesia (P=0.048).
One study compared two methods of cervical block
and found no significant difference in pain between a
paracervical and a uterosacral ligament local block
(P<0.65).
23 Two studies compared local anaesthetic
with other medication.
2122 The first compared intra-
cervical local anaesthetic with a control group (data
usedinmeta-analysis)andwithintramuscularinjection
of 100 mg tramadol. Tramadol was significantly better
thanintracervicalblockatreducingtheamountofpain
experiencedduringhysteroscopy(P=0.001).
21Thesec-
ond study compared paracervical injection of local
anaesthetic with the use of conscious sedation for
operativehysteroscopyandfoundnosignificantdiffer-
enceinthepainexperiencedbetweenthetwogroups.
22
Vasovagal episodes
There was no significant difference in the incidence of
vasovagalepisodesbetweenlocalanaestheticand con-
trol (nil, normal saline, placebo, conscious sedation)
groups (P=0.09, fig 5), regardless of definition of vaso-
vagal reaction.
DISCUSSION
Local anaesthetic reduces the pain experienced by
women during outpatient hysteroscopy. This occurs
with paracervical and intracervical injections of anaes-
thetic but not with transcervical and topical applica-
tion. Paracervical injection seems to be the most
effective method of administering local anaesthetic
for the procedure. Local anaesthetic did not signifi-
cantlyreducetheincidenceofvasovagalattacksduring
outpatient hysteroscopy, but there was a beneficial
trend.
Strengths and limitations
Many aspects of the review lead us to believe that our
results are valid. Firstly, we formulated a clinically
focused question and then performed comprehensive
searches that encompassed multiple online databases
aswellassearchingofthereferencesectionsofrelevant
studies. We had no language restriction, and we used
broad search terms to avoid making the question too
specifictobeadequatelysensitive.Wedidnotseekany
unpublished data and therefore there is a risk of
Table 3 |Characteristics of studies that used normal saline as distension medium included in systematic review of use of local anaesthetic
Study Participants Intervention Comparison Outcome measure Data reported
Al-Sunaidi
36 Women undergoing diagnostic outpatient
hysteroscopy for evaluation of uterine cavity.
Exclusions: women needing operative
hysteroscopy under GA, positive chlamydia
culture, pregnancy, or allergy to local
anaesthetic
Intracervicalinjectionof2ml0.5%
bupivacaine and paracervical
injection of 8 ml 0.5%
bupivacaine, 5 minutes before
procedure, n=42
Intracervicalinjectionof2ml0.5%
bupivacaine, 5 minutes before
procedure. n=42
VAS 0-10, completed during
procedure and at 10, 30, and
60 minutes after
Mean (SD)
Guida
22 Women undergoing operative outpatient
hysteroscopy for surgically treatable lesions
associatedwithinfertilityorabnormaluterine
bleeding
Paracervicalinjectionof10ml1%
mepivacaine, n=82
Conscious sedation with 0.5 mg
atropine iv, 0.25 mg fentanyl iv,
and 2 mg midazolam iv, n=84
5 cm VAS used during,
immediately after, 15, and
60 minutes after and 24 and 72
hours after procedure
Mean (SD)
Kabli
39 Infertile women undergoing outpatient
hysteroscopy. Women needing operative
hysteroscopy under GA, positive chlamydia
culture, pregnancy, or allergy to local
anaesthetic were excluded.
Intracervical injection of 2 ml 1%
lidocaine and distension media
with 18 ml lidocaine/250 ml
saline, n=42
Intracervical injection of 2 ml 1%
lidocaine, n=36
VAS 0-10 used to score pain after
hysteroscopy, after endometrial
biopsy, and at 10, 30, and
60 minutes after procedure
Mean (SD)
Sagiv
26 Women undergoing diagnostic outpatient
hysteroscopy
Intracervicalinjectionof10ml3%
mepivacaine, n=47
Vaginoscopy (performed without
speculum or anaesthesia), n=83
VAS 0-10 cm used to score pain
immediatelyand15minutesafter
hysteroscopy
Mean (SD)
Shankar
33 Women with abnormal uterine bleeding
referred by GP for diagnostic outpatient
hysteroscopy.Exclusions:unabletovisualise
cervix or severe cervical stenosis
Distension media containing
40 ml 2% lidocaine/500 ml 0.9%
saline, n=100
Distension media of 0.9% saline
only, n=100
PainscoredwithVAS0-10,andPPI Mean (SD)
Soriano
34 Women undergoing diagnostic hysteroscopy
for abnormal uterine bleeding or infertility.
Women with menorrhagia at time of
procedure, sensitivity to lidocaine, epilepsy,
impaired respiratory or cardiac function, and
active liver disease excluded
5% lidocaine sprayed on to
endocervixandintocervicalcanal,
(3spraysintotal)5minutesbefore
procedure, n=62
Same procedure with placebo
spray, n=56
VAS 0-10 cm to score pain
experienced during procedure
Mean (SD)
GA=general anaesthesia; PPI=present pain intensity scale (verbal descriptors of pain ranked from 0-5 on numerical scale).
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possibility of publication bias indicated that we might
havemissedstudiesthatreportnobenefitofusinglocal
anaesthetic for outpatient hysteroscopy. We restricted
study design to randomised controlled trials to mini-
miseselectionbias.Wewereunabletoexplorereasons
for heterogeneity in the subgroups by method of
administration because of insufficient power caused
by the small number of studies per subgroup. We
graded the quality of our studiesin subgroups,accord-
ing to strict predetermined criteria, to examine for the
overall heterogeneity. Heterogeneity was reduced in
the high quality subgroup, but I
2 was still 83%. Meta-
analysis of the high quality studies found a significant
reduction in pain with the use of local anaesthetic, a
finding that was consistent with and thus supportive
of our overall findings. Intracervical injection of local
anaesthetic was associated with a significant reduction
in pain during outpatient hysteroscopy, but the
strengthofthisfindingislimited.Thisisbecauseasen-
sitivity analysis excluding a study in which categorical
datahadbeentransformedshowednobeneficialeffect
of intracervical injection, although this finding was
associated with increased heterogeneity.
Comparison with other studies
Toourknowledge,thisistheonlysystematicreviewto
assesstheeffectoflocalanaestheticonpainduringout-
patient hysteroscopy. A Cochrane review assessed the
use of paracervical injection for various obstetric and
gynaecological procedures, including hysteroscopy,
endometrial biopsy, fractional curettage, vacuum
aspiration, suction termination of pregnancy, or eva-
cuationofretainedproductsofconceptionand biman-
ual removal of retained placenta.
4 Only three studies
involving hysteroscopy were included in the review
and only two in meta-analysis. The conclusion that
the use of paracervical injection does not reduce the
painof “uterine intervention” cannot be appliedspeci-
fically to hysteroscopy. Our meta-analysis contains
five studies assessing paracervical anaesthesia in hys-
teroscopy and so has greater power, adding weight to
our findings. Moreover, intracervical and topical
administration of local anaesthesia is more commonly
used in ambulatory hysteroscopy than paracervical
approaches.
41 Our review assesses all routes of admin-
istration of local anaesthetic, thereby providing rele-
vant guidance to clinicians for one of the most
common interventions in gynaecology.
Clinical implications of the review
Injectable, preferably paracervical, administration of
local anaesthetic should be used for women under-
going hysteroscopy as outpatients to reduce the
amount of pain experienced. Topical application of
local anaesthetic does not reduce the pain of the hys-
teroscopy but should be used when a tenaculum is
applied to the cervix. Only one study examined the
use of local anaesthetic for operative hysteroscopy
22
and therefore our results do not adequately address
the benefit of local anaesthetic in this variation of the
procedure.Althoughourconclusionsshowabenefitof
using local anaesthetic, we could not review data on
harms because this was not explicitly reported by
most studies except when they referred to symptoms
caused by vagal stimulation (hypotension, bradycar-
dia, nausea, vomiting, etc). Similar symptoms, how-
ever, might arise from intravasation of injected local
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Fig 3 | Jadad quality assessment of studies examining use of
local anaesthetic for outpatient hysteroscopy
Table 4 |Characteristics of studies that used other distension media* included in systematic review of use of local anaesthetic
Study Participants Intervention† Comparison Outcome measure Data reported
Distension medium 1.5% glycine
Vercellini
37 Premenopausal (FSH <30 mIU/ml) non-
pregnant (negative β-hCG test) women
referred for investigation of excessive uterine
bleeding of for ≥3 months. Women with
genital infection, previous cervical surgery or
hysteroscopy, severe cardiac disease, and
known sensitivity to local anaesthetics were
excluded
Paracervical injection of 1%
mepivacaine more than
5 minutes before procedure,
n=87
No anaesthesia, n=90 10pointVASusedtoscorepain
during hysteroscopy and
endometrial biopsy
Mean (SD)
Distension medium not stated
Finikiotis
13 Patients referred from GPs and from other
gynaecologists for investigation of various
gynaecological complaints
Paracervical injection of 16-
20 ml 1% lidocaine, n=60
Uterosacral injection of 2 ml
2% lidocaine with 1:80 000
adrenaline, n=60
VAS0-10cmtoscorepainduring
procedure. Reported as No of
patients selecting VAS 0-3.3,
3.4-6.3, and 6.4-10.0
Mean (SD) calculated from
mean value of each category
VAS=visual analogue scale, GP=general practitioner.
*Other than carbon dioxide or normal saline.
†For consistency the group receiving local anaesthetic (or combination of anaesthetics) are considered as intervention group even if that was not the case in original study.
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use of local anaesthetic for outpatient hysteroscopy
are likely to be underestimated. For example, the
time taken to perform the block prolongs the proce-
dure, and the pain scores might not take into account
the pain experienced during injection of local anaes-
thetic, in itself a painful procedure. In fact one study
found that a vaginoscopic approach to hysteroscopy
wassignificantlylesspainfulthanhavingtheprocedure
done traditionally with a vaginal speculum and a local
anaesthetic block.
26
Outpatient hysteroscopy is a multi-faceted proce-
dure, and there are many factors that contribute
towards pain. These can be categorised into factors
related to the patient (such as menopausal status, rea-
son for hysteroscopy) and procedural factors (such as
thetypeofdistensionmedia,useofaspeculum,useofa
rigid or flexible hysteroscope). The small number of
Intracervical
  Broadbent 199227
  Esteve 2002
35
  Bellati 199821
Subtotal
Test for heterogeneity: τ2=0.00, χ2=1.98, df=2, P=0.37, I2=0%
Test for overall effect: z=2.72, P=0.007
Paracervical
  Lau 199916
  Cicinelli 1998
15
  Vercellini 199437
  Giorda 2000
30
  Al-Sunaidi 200736
Subtotal
Test for heterogeneity: τ2=1.08, χ2=115.85, df=4, P<0.001, I2=97%
Test for overall effect: z=2.69, P=0.007
Transcervical
  Cicinelli 199714
  Costello 199838
  Lau 200032
  Kabil 2008
39
  Shankar 2004
33
Subtotal
Test for heterogeneity: τ2=0.01, χ2=5.50, df=4, P=0.24, I2=27%
Test for overall effect: z=1.04, P=0.30
Topical
  Soriano 200034
  Wong 200040
Subtotal
Test for heterogeneity: τ2=0.20, χ2=10.00, df=1, P=0.002, I2=90%
Test for overall effect: z=0.98, P=0.33
Total
Test for heterogeneity: τ2=0.33, χ2=158.49, df=14, P<0.001, I2=91%
Test for overall effect: z=3.43, P<0.001
High quality studies
Test for heterogeneity: τ2=0.17, χ
2=47.15, df=8, P<0.001, I
2=83%
Low quality studies
Test for heterogeneity: τ
2=0.69, χ
2=110.31, df=5, P<0.001, I
2=95%
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Fig 4 | Effect of local anaesthetic on pain during outpatient hysteroscopy, according to method of administration and quality of
study. Figures are mean (SMD) pain scores
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the patients according to menopausal status and indi-
cation for hysteroscopy. Confounding caused by pro-
cedural factors should be eradicated because we
restricted studies to randomised controlled trials.
Unanswered questions and future research
Is the pain that women feel during a hysteroscopy
enough to warrant the use of anaesthetic? It might
cause a considerable reduction in the amount of pain
experienced, but in most studies the mean pain scores
in the intervention and control groups showed little
variation and tended to be low anyway. Selection of
individual cases must be considered as important in
the assessment of who will benefit the most from the
useoflocalanaesthetic.Parouspremenopausalwomen
arelesslikelytobenefitastheyprobablyhavelessnar-
rowing of the cervical canal, whereas nulliparous post-
menopausal women, who will almost certainly have a
degree of cervical stenosis, might benefit greatly. Our
results cannot quantify this benefit. It might be that
alteringaspectsoftheprocedure(suchasvaginoscopy,
warming the liquid distension media, distension pres-
sures)canreducethepainconsiderablywithouttheuse
of a local anaesthetic injection. There are obvious cost
implications(forequipmentandmedication,aswellas
reducing the number of people seen in clinic) of using
local anaesthetic for every patient who undergoes an
outpatient hysteroscopy.
There is a need for large trials comparing how the
different hysteroscopic techniques (such as vagino-
scopyversusatraditionalhysteroscopywithorwithout
local anaesthesia, type of distension media, use of a
flexible or rigid scope, cervical preparation) affect
pain, feasibility, and the incidence of vasovagal epi-
sodes during outpatient hysteroscopy. Such trials
shouldexplicitly define and standardisethe procedure
and systematically examine acceptability and quality
of life, in addition to alleviation of pain. These qualita-
tive outcomes can then be correlated with pain scores
to see if any reported reduction in pain during outpa-
tient hysteroscopy is actually clinically meaningful.
Studies also need to look at patients’ factors, such as
parity and menopausal status, to determine case selec-
tion—that is, who will benefit the most from routine
administrationofinjectablelocalcervicalanaesthetics.
Research trials should also evaluate administration of
local anaesthetic and hysteroscopic technique in
operative outpatient hysteroscopic surgery, which is
becoming increasingly prevalent with technological
advances in endoscopic instrumentation.
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